Srivastava A, Mathews V. Hairy cell leukaemia--therapeutic options. JAssoc Physicians India. 2001;49:783-784.
Mathews V*, Chandy M, Srivastava A. Arsenic trioxide in the management of acute promyelocytic leukaemia. Natl Med J India. 2001;14:215-222.
Mathews V*, Balasubramanian P, Shaji RV, George B, Chandy M, Srivastava A. Central nervous system relapse in a patient with acute promyelocytic leukaemia treated with arsenic tri-oxide. Br J Haematol. 2001;113:257-258.
Joseph G, Mathews V, Perakath B, Joseph P, Sitaram V. Relentless progression of venous obstruction in a case of Budd-Chiari syndrome related to heterozygous protein C deficiency. Cardiovasc Intervent Radiol. 2001;24:427-431.
George B, Mathews V, Srivastava V, Srivastava A, Chandy M. Tuberculosis among allogeneic bone marrow transplant recipients in India. Bone Marrow Transplant. 2001;27:973-975.
George B, Danda D, Chandy M, Srivastava A, Mathews V. Polymyositis--an unusual manifestation of chronic graft-versus-host disease. Rheumatol Int. 2001;20:169-170
Finny GJ, Mathews V, Abraham P, Abraham M, Chandy M, Srivastava A, Nitsche A, Siegert W, Sridharan G. A pilot study on the role of cytomegalovirus & human herpesvirus-6 infections in Indian bone marrow transplant recipients. Indian J Med Res. 2001;114:39-46
Chandy M, Srivastava A, Dennison D, Mathews V, George B. Allogeneic bone marrow transplantation in the developing world: experience from a center in India. Bone Marrow Transplant. 2001;27:785-790.
2000
Mathews V*, Srivastava A, Nair SC, Chandy M. Haemostasis with cryoprecipitate in patients undergoing surgery for severe von Willebrand disease. Natl Med J India. 2000;13:188-190.
V.Mathews , A Srivastava, SC Nair, M Chandy . Hemostasis with cryoprecipitate in patients undergoing surgery for severe von Willebrand’s disease. Natl Med J Ind 2000 13: 188-190.
M.Chandy. Autologous bone marrow transplantation. Natl Med J of India 2000; 13: 55-57
1999
Goeorge K, George SS, Janes C, Fernandez HA, Shaji RV, Srivastava A, Chandy M. Transvaginal Chorionic Villus Sampling – an Alternative Approach. Aust NZ Obstet Gynaecol 1999:4: 489-491.
Poonkuzhali B, Srivastava A, Quernin MH, Dennison D, Aigrain EJ, Kanagasabapathy AS, Krishnamoorthy R, Chandy M Pharmacokinetics of oral busulphan in children with beta thalassaemia major undergoing allogeneic bone marrow transplantation.. Bone Marrow Transplantation 1999; 24, 5-11
Mathew JG, Chandy M, Dennison D, Srivastava A, Ganapathy K, Cherian T. Successful Bone Marrow Transplantation in an Infant with Wiskott-Aldrich Syndrome . Indian Pediatrics (1999) 36:707-710.
Srivastava A, Nair SC, Srivastava VM, Balamurugan AN, Jeyaseelan L, Chandy M and Gunasekaran S Evaluation of uroprotective efficacy of amifostine against cyclophosphamide induced hemorrhagic cystitis. Bone Marrow Transplantation 1999; 23: 463-467.
MH.Quernin, B.Poonkuzhali, Y.Medard, D.Dennison, A.Srivastava, R.Krishnamoorthy, M.Chandy & EJ Aigrain High-performance liquid chromatographic method for quantification of busulfan in plasma after derivatization by tetrafluorothiophenol. J Chromatogr 1999; 721: 147-152.
A.Srivastava, NEJ Remington, RV.Shaji, M.Chandy . Prevalence of Factor V G 1691 A mutation and prothrombin variant G20210 A in India. Thromb Haemost (Suppl 73)1999; 219a.
V Mathews, Srivastava A, George B, Chandy M. Role of Arsenic trioxide in the management of APML. Ind J Hematol Blood Trans Dec 1999.
8. Sharma A, Srivastava A, Mathews V, George B, Chandy M. Fludarabine, busulfan and anti-thymocyte globulin conditioning for allogeneic bone marrow transplantation for severe aplastic anaemia. Ind J Haematol Blood Trans 1999; 17 (Suppl. 1):15.